Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Y Wang, QF Liu, LP Xu, KY Liu… - Blood, The Journal …, 2015 - ashpublications.org
The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first …
S Yu, F Huang, Y Wang, Y Xu, T Yang, Z Fan, R Lin… - Leukemia, 2020 - nature.com
This study aimed to investigate graft-versus-leukemia (GVL) of haploidentical donor (HID)
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
W Saber, S Opie, JD Rizzo, MJ Zhang… - Blood, The Journal …, 2012 - ashpublications.org
Approximately one-third of patients with an indication for hematopoietic cell transplantation
(HCT) have an HLA-matched related donor (MRD) available to them. For the remaining …
(HCT) have an HLA-matched related donor (MRD) available to them. For the remaining …
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in …
JJ Cornelissen, WLJ Van Putten, LF Verdonck… - Blood, 2007 - ashpublications.org
Abstract The Dutch-Belgian Hemato-Oncology Cooperative Group and the Swiss Group for
Clinical Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of …
Clinical Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of …
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
A Rashidi, M Hamadani, MJ Zhang, HL Wang… - Blood …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable …
V Gupta, MS Tallman, W He, BR Logan… - Blood, The Journal …, 2010 - ashpublications.org
We compared the outcomes of unrelated donor (URD, n= 358) with human leukocyte
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
YJ Chang, Y Wang, LP Xu, XH Zhang, H Chen… - Journal of hematology & …, 2020 - Springer
Background Previous reports suggest a benefit associated with haploidentical donor
transplantation (HIDT) compared to matched sibling donor transplantation (MSDT) in certain …
transplantation (HIDT) compared to matched sibling donor transplantation (MSDT) in certain …
Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized …
YU Wang, QF Liu, LP Xu, KY Liu, XH Zhang, X Ma… - Clinical Cancer …, 2016 - AACR
Purpose: Although matched-sibling donor (MSD) hematopoietic stem-cell transplantation
(HSCT) has an established role in the management of adults with acute lymphoblastic …
(HSCT) has an established role in the management of adults with acute lymphoblastic …
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
S Piemontese, F Ciceri, M Labopin, W Arcese… - Journal of hematology & …, 2017 - Springer
Background In the absence of a HLA-matched related or matched unrelated donor,
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …
[HTML][HTML] Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia …
D Salvatore, M Labopin, A Ruggeri, G Battipaglia… - …, 2018 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …